TH
BIB icon

Timber Hill’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Timber Hill’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,938
Closed -$721K – 1028
2017
Q1 		$721K Sell
14,938
-7,289
-33% -$339K 0.01% 1274
2016
Q4 		$887K Buy
22,227
+667
+3% +$28.5K ﹤0.01% 1340
2016
Q3 		$1.04M Sell
21,560
-7,883
-27% -$375K 0.01% 1100
2016
Q2 		$1.14M Buy
29,443
+2,175
+8% +$93.8K 0.01% 1187
2016
Q1 		$1.11M Buy
+27,268
New +$1.21M 0.01% 1201

Other funds holding BIB

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
RIA
RPG Investment Advisory Pleasanton, California $829M AUM 36.68% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BRC
Bell Rock Capital Rehoboth Beach, Delaware $81M AUM 9.85% 1-Year Est. Return

Timber Hill's BIB Position: Q2 2017 in Review

Timber Hill sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2017, closing a stake of 14,938 shares — an estimated $721K sold.

Timber Hill first reported a position in BIB in Q1 2016 and held it in 5 quarters. The position peaked at $1.14M in Q2 2016. 32 funds tracked by Wall St. Rank hold BIB as of Q2 2017.

  • Timber Hill reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 14,938 ProShares Ultra NASDAQ Biotechnology shares in Q2 2017, an estimated $721K.
  • Timber Hill first reported a position in ProShares Ultra NASDAQ Biotechnology in Q1 2016 and held it in 5 quarters.
  • Timber Hill's ProShares Ultra NASDAQ Biotechnology position peaked at $1.14M in Q2 2016.
  • 32 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.